Two lacto-N-biose phosphorylase (LNBP) isozyme genes were cloned from Bifidobacterium bifidum JCM1254. Alignment of the amino acid sequences of LNBP and its homologs identified 24 completely conserved acidic amino acid residues. All single mutants of Bifidobacterium longum LNBP at residues other than D313N retained considerable activity, suggesting that Asp313 is the putative proton donor residue in LNBP.
Lacto-N-biose phosphorylase (LNBP, EC 2.4.1.211) is an inverting phosphorolytic enzyme that cleaves lacto-N-biose I (Gal1!3GlcNAc, LNB) and galacto-Nbiose (Gal1!3GalNAc, GNB), the core structures of human milk oligosaccharides and mucin sugar chains respectively, yielding -galactose 1-phosphate (Gal1P) and the corresponding N-acetylhexosamine. LNBP activity was first identified in cell free extract of Bifidobacterium bifidum DSM20082. 1) On purifying LNBP from this strain, we found that its partial amino acid sequence was highly homologous to the BL1641 protein (annotated as a hypothetical protein) of Bifidobacterium longum NCC2705, whose genomic sequence was available.
2) Successful cloning and expression of an LNBP gene (lnpA) from the type strain, B. longum JCM1217, which was almost identical to BL1641, confirmed the LNBP activity of the recombinant enzyme.
3) Several genes related to the metabolism of galactose, which resembles with Leloir pathway, are clustered around BL1641, suggesting that they constitute a major galactose-metabolizing pathway. 3) Intestinal colonization by bifidobacteria is mediated by the recognition and metabolism of mucin carbohydrate. 4, 5) Thus, by utilizing GNB hydrolyzed from mucin by endo--N-acetylgalactosaminidase, 6 ) LNBP might be a key enzyme in the intestinal colonization of these bacteria. 1, 3) We have also hypothesized that LNBP plays a key role in the rapid intestinal colonization of bifidobacteria in breast-fed infants by utilizing the LNB structure present in human milk oligosaccharides. 3) To date, LNBP has not been found to have significant identity to any proteins of known function.
3) Genes homologous to lnpA, however, have been identified in six bacterial strains of four species, B. longum NCC2705
2) and DJO10A, Clostridium perfringens strain 13, 7) Vibrio vulnificus CMCP6 8) and YJ016, 9) and Propionibacterium acnes KPA171202. 10) All of these strains are related to humans commensally or pathogenically: bifidobacteria are probiotic bacteria; P. acnes is a major inhabitant of adult human skin; and C. perfringens and V. vulnificus cause food poisoning and serious myonecrotic lesions and septicemia respectively, by growing in human tissues after invading through injuries. Since LNBP and its homologs might be key enzymes underlying the ability of these bacteria to reside in the human body, studies of this new class of enzyme should increase understanding of their mechanisms of colonization.
The 3D structures of three inverting phosphorolytic enzymes belonging to two families {glycoside hydrolase (GH) family 11) 65 and 94} have been solved. [12] [13] [14] The two families share the same catalytic mechanism, one acidic amino acid residue (Glu for GH65 maltose phosphorylase, Asp for GH94 chitobiose phosphorylase and cellobiose phosphorylase) being the proton donor, and phosphate directly attacking the C1 of the glycoside as catalytic nucleophile. Mutations at their respective acidic residues completely abolished their enzymatic activities. 12, 13) Due to this mechanism, these enzymes share similar pH profiles with neutral optimum pH. 15, 16) Since LNBP showed a similar pH profile, LNBP probably shares the same catalytic mechanism with other inverting phosphorolytic enzymes. Hence, we planned to identify the proton donor residue of LNBP by mutating
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y To whom correspondence should be addressed. Fax: +81-29-838-7321; E-mail: mkitaoka@affrc.go.jp Abbreviations: BL1641, lacto-N-biose I phosphorylase homolog from Bifidobacterium longum NCC2705; GNB, galacto-N-biose; LNB, lacto-Nbiose I; LNBP, lacto-N-biose phosphorylase; LNBP1 and LNBP2, isozymes of LNBP from Bifidobacterium bifidum JCM1254; lnpA, LNBP gene from Bifidobacterium longum JCM1217; lnpA1 and lnpA2, LNBP isozyme genes from Bifidobacterium bifidum JCM1254; ORF, open reading frame Biosci. Biotechnol. Biochem., 71 (6), [1587] [1588] [1589] [1590] [1591] 2007 Note conserved acidic amino acid residues to find the mutation causing disappearance of the activity. To decrease the number of candidates, initially we tried to increase the number of amino acid sequences to be aligned by cloning lnpA from B. bifidum, which gene product had already been purified. 3) PCR was performed using KOD-Plus polymerase (Toyobo, Osaka, Japan) and primers synthesized on the basis of N-terminal and internal amino acid sequences from B. bifidum LNBP 3) and the genomic sequence of B. longum NCC2705 (shown in Fig. 1) . B. bifidum JCM1254 genomic DNA was prepared using InstaGene (Bio-Rad, Hercules, CA) according to the manufacturer's instructions. The nucleotide sequence of PCR products was determined after gene cloning using a TOPO TA cloning kit (Invitrogen, Carlsbad, CA). The 5 0 and 3 0 terminal sequences were confirmed by the TAIL-PCR method. 17) First, a portion of the lnpA gene homolog (lnpA1) was amplified by PCR using B. bifidum genomic DNA as template and primers 2 and 7, as shown in Fig. 1 , designed on the basis of the internal amino acid sequences of LNBP. To identify the entire open reading frame (ORF) of lnpA1, the 5 0 terminal region was cloned by PCR using primers 1 and 6 ( Fig. 1) designed from the BL1640 (annotated as permease of ABC transporter for sugars) and lnpA1 sequences, and the 3 0 terminal region was cloned by TAIL-PCR using forward primers 3, 4, and 5 and reverse random primer 8 (Fig. 1) . The length of lnpA1 was identical to that of lnpA from B. longum JCM1217, and their deduced amino acid sequences were 90% identical. The BL1640 homologous gene was in B. longum JCM1217, but the BL1642 (annotated as putative desulfatase possibly for mucin) homologous sequence was not found in the TAIL-PCR product (Fig. 1) . The deduced amino acid sequence of lnpA1 ORF was not consistent with the previously reported peptide sequences from purified LNBP, 3) indicating that purified LNBP is encoded by a different gene (lnpA2). To isolate lnpA2, nucleotide sequences of the PCR product (approximately 650 bp) amplified by lnpA1 forward primer 3 and reverse primer 7 ( Fig. 1 ) from several clones were determined, and a sequence different from that of lnpA1 was identified. Its deduced ORF was similar to that of lnpA1 and contained internal amino acid sequences identical to that of the purified enzyme. The remaining portions of the lnpA2 gene were cloned by TAIL-PCR using forward random primer 9 and reverse primers 13, 14, and 15 for the 5 0 terminus, and forward primers 11 and 12 and reverse random primer 9 for the 3 0 terminus, as shown in Fig. 1 . The entire cloned lnpA2 gene had a deduced amino acid sequence completely identical to that of the fragments of the purified enzyme. It was located upstream of a gene homologous with BL0348 (Fig. 1) . Two possible ORFs were found upstream of lnpA2, but no gene homologous to either of the ORFs was present in the B. longum Arrows with numbering indicate primers using gene cloning. The arrows facing down and up represent forward and reverse primers respectively. The nucleotide sequences from the 5 0 to the 3 0 terminus of them are shown as follows: 1, tgctgttcctcggcctccagcgctactggc; 2, aaagaccaaggaactcgccgaattgtgggg; 3, gcgctgccgaacaagcagacgtat; 4, gtgtggaagaacccgaagctgaccgagacc; 5, gaagcgtgggagaaggccggataccgcatc; 6, ctctccgacgccgacgaatgctcc; 7, gagcacgggttcgccgaagtcgatgccgcc; 8, ngtcgaswganawgaa; 9, ttcwtntcwstcgacn; 10, gagatgtacaaccacctgacgaac; 11, ccgagcgcccagcagttccagggtc; 12, ggcgaaggtgtgctgcagggcttcctcgac; 13, gttcgtcaggtggttgtacatctc; 14, ccatgcggagttgtacgagccctcgtt; 15, atacgtctgcttgttcggcagcgc.
NCC2705 genome. The length of the lnpA2 ORF was also identical to those of the lnpA and lnpA1 ORFs. The lnpA2 ORF was approximately 80% identical in amino acid sequences for the lnpA and lnpA1 ORFs.
To confirm the LNBP activity of the proteins encoded by lnpA1 and lnpA2, we prepared recombinant enzymes as described below. Both lnpA1 and lnpA2 were amplified from the genomic DNA using the corresponding forward primers having a NcoI site (lnpA1, 5
0 -gaaccatggccagcactggccgcttcacattgc-3 0 ; lnpA2, 5 0 -ggaacatccatggcaacttctggccgtttacgatt-3 0 ) and reverse primers having a XhoI site (lnpA1, 5
0 -acagactcgaggttgcgccaagcgatggcgctc-3 0 ; lnpA2, 5 0 -tgcgaccctcgaggatggtgcgccaggcgataccgctgg-3 0 ). The amplified products were inserted into pET28 vector (Novagen, Darmstadt, Germany) at the NcoI/XhoI sites using a Ligation High DNA ligation kit (Toyobo, Osaka) after amplification by PCR to add restriction endonuclease sites and treatment with NcoI and XhoI. The plasmids were designed to allow a histidine tag sequence to be added at the carboxyl terminus of each enzyme to facilitate purification. After confirming the sequence, plasmid DNA was used to transform Escherichia coli BL21 (DE3). Each transformant was cultivated at 30 C with shaking in 100 ml LB medium containing 50 mg/ml kanamycin until the absorbance at 600 nm reached 0.5. Protein expression was induced by the addition of isopropyl 1-thio--D-galactoside at a final concentration of 0.5 mM, followed by incubation for a further 20 h at 30 C with shaking. The cells were harvested by centrifugation at 15;000 Â g for 10 min, resuspended in 20 mM MOPS buffer (pH 7.5), and sonicated (Branson Ultrasonic Corporation, Danbury, CT), and the cell debris was removed by centrifugation at 17;000 Â g for 30 min. Each enzyme was purified using a Ni-NTA spin column (Qiagen, Hilden, Germany), as described by the manufacturer. The homogeneity of the purified enzymes was confirmed by SDS-PAGE. Protein concentrations were determined using theoretical extinction coefficients calculated from the amino acid sequences of the proteins. 18) The phosphorolytic reactions of LNB and GNB by the recombinant enzymes encoded by the lnpA1 (LNBP1) and lnpA2 (LNBP2) genes were confirmed by the production of Gal1P and the corresponding N-acetylhexosamines in reaction mixtures containing 10 mM LNB or GNB in 100 mM MOPS buffer (pH 7.5), as assessed by thin layer chromatography on a silica gel plate (Silica gel 60 F254; Merck, Darmstadt, Germany) developed with acetonitrile-water (4:1). Both enzymes showed the phosphorolytic activity of both the substrates. LNBP activity was quantified by determining the increase in the concentration of phosphate in a reaction mixture containing 10 mM Gal1P and 10 mM GlcNAc in 100 mM MOPS buffer (pH 7.5) at 37 C, 19) with 1 unit of enzyme activity defined as the amount of enzyme that liberated 1 mmol of phosphate per min under the above conditions. The specific activities of LNBP1 and LNBP2 were 10.5 U/mg and 10.0 U/mg respectively, virtually identical to that of LNBP from B. longum JCM1217 (11.6 U/mg). These results indicate that two LNBP isozyme genes are present in the B. bifidum JCM1254 genome.
When B. bifidum JCM1254 was cultivated in medium containing glucose as the sole carbon source, only LNBP2 was detected throughout the purification steps. 3) In addition, LNBP activity was not detected in B. longum JCM1217 cells cultivated in the same medium. 3) Because lnpA1 of B. bifidum JCM1254 and lnpA of B. longum JCM1217 appear to be located at similar loci, the behaviors of the expression of the genes might be same (inducible, repressive, or silent), whereas that of lnpA2 of B. bifidum JCM1254 is constitutive. This constitutive expression might be related to the constitutive production of galactose-metabolism enzymes by B. bifidum.
20)
Multiple alignment of nine amino acid sequences of LNBP [B. longum JCM1217 (GenBank accession number, BAD80751), B. bifidum JCM1254 (this study, lnpA1 and lnpA2)] and LNBP homologs [B. longum NCC2705 (AAN25428) and DJO10A (ZP 00121798), C. perfringens 13 (BAB80279), P. acnes KPA171202 (AAT81843), V. vulnificus YJ016 (BAC97640) and CMCP6 (AAO07997)] using Genetyx software (Genetyx, Tokyo) showed that 24 acidic amino acid residues were identical in all nine sequences. Each of these Asp and Glu residues in LNBP of B. longum JCM1217 was individually replaced by Asn or Gln by quick change methods 21) with its expression vector 3) as template. The enzymatic activities of each of these mutants were measured. Compared with the wild-type enzyme, all mutants showed decreases in specific activity (Table 1) , with mutants D29N, D160N, E319Q, and E356Q retaining less than 3% of the activity of the wild-type enzyme. This finding suggests that these three acidic residues are important for activity, and are perhaps involved in substrate recognition or protein folding. In contrast to these mutants, the activity of the D313N mutant was undetectable. The circular dichroism spectrum of D313N was identical with that of the wild-type enzyme, indicating that D313N folded properly (Fig. 2) . Mutations at the proton donor residue in inverting phosphorolytic enzymes such as maltose phosphorylase and chitobiose phosphorylase caused complete losses of their activities. 12, 13) This result strongly suggests that Asp313 is the catalytic proton donor residue of LNBP. Since mutations at all other conserved acidic amino acid residues retained significant activity, it is likely that LNBP shares the same reaction mechanism with other inverting phosphorolytic enzymes. This finding should be useful in further studies on this new family of enzymes.
